This volume covers the emerging area of science, Clinical Lipidomics, which is the application of lipidology to the understanding of physiological and pathophysiological changes of lipidomes, with a special focus on lipidomic profiles in human diseases.
Lipidomics is widely used to map lipid molecular species in a biological system. Clinical lipidomic analysis has demonstrated the comprehensive characterization of molecular lipids in various severities, durations, and therapies as a critical tool in identification and validation of disease-specific biomarkers.
This volume on Clinical Lipidomics will add to the literature and help advance the knowledge of the pathogenesis, diagnosis, prevention and treatment of diseases.
Table of Content
Chapter 1. Clinical Lipidomics: A Critical Approach for Disease Diagnosis and Therapy.- Chapter 2. The role of lipid metabolism in the development of lung cancer.- Chapter 3. Bioinformatics of Embryonic Exposures: Lipid Metabolism and Gender as Biomedical Variables.- Chapter 4. An Evaluation of Multivariate Data Analysis Models for Lipidomic Parameters from Patients with Metabolic Syndrome Undergoing Remedial Treatment.- Chapter 5. Lipidomics in carotid artery stenosis: further understanding of pathology and treatment.- Chapter 6. Metabolomics of Immunity and Its Clinical Applications.- Chapter 7. Urinary Lipidomics.- Chapter 8. Breast cancer and lipid metabolism.- Chapter 9. Association of circulating oxidized lipids with cardiovascular outcomes.- Chapter 10. Lipidomics: Mass Spectrometry Based Untargeted Profiling and False Positives.- Chapter 11. Phospholipid and Phospholipidomics in Health and Diseases.
About the author
Dr. Xiangdong Wang is Distinguished Professor at Zhongshan Hospital Fudan University.